Redhill Biopharma Ltd. 6-K Filing
Ticker: RDHL · Form: 6-K · Filed: Nov 26, 2025 · CIK: 1553846
| Field | Detail |
|---|---|
| Company | Redhill Biopharma Ltd. (RDHL) |
| Form Type | 6-K |
| Filed Date | Nov 26, 2025 |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Redhill Biopharma Ltd. (ticker: RDHL) to the SEC on Nov 26, 2025.
How long is this filing?
Redhill Biopharma Ltd.'s 6-K filing is 1 pages with approximately 425 words. Estimated reading time is 2 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 425 words · 2 min read · ~1 pages · Grade level 7.2 · Accepted 2025-11-26 16:02:09
Filing Documents
- zk2534069.htm (6-K) — 11KB
- exhibit_5-1.htm (EX-5.1) — 10KB
- exhibit_5-2.htm (EX-5.2) — 9KB
- image00003.jpg (GRAPHIC) — 14KB
- image00004.jpg (GRAPHIC) — 781KB
- image00006.jpg (GRAPHIC) — 6KB
- 0001178913-25-003963.txt ( ) — 1135KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. REDHILL BIOPHARMA LTD. (the "Registrant") Date: November 26, 2025 By: /s/ Dror Ben-Asher Name: Dror Ben-Asher Title: Chief Executive Officer